Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.
Ecker J, Oehme I, Mazitschek R, Korshunov A, Kool M, Hielscher T, Kiss J, Selt F, Konrad C, Lodrini M, Deubzer HE, von Deimling A, Kulozik AE, Pfister SM, Witt O, Milde T.
Ecker J, et al. Among authors: deubzer he.
Acta Neuropathol Commun. 2015 Apr 3;3:22. doi: 10.1186/s40478-015-0201-7.
Acta Neuropathol Commun. 2015.
PMID: 25853389
Free PMC article.